Paul Chaplin
Chief Executive Officer bei BAVARIAN NORDIC A/S
Profil
Paul Chaplin is currently the President & Chief Executive Officer at Bavarian.
Nordic A.
He is also the President at Bavarian Nordic, Inc. Additionally, he serves as the General Manager at Bavarian Nordic GmbH.
Dr. Chaplin holds a doctorate degree from the University of Bristol.
Aktive Positionen von Paul Chaplin
| Unternehmen | Position | Beginn |
|---|---|---|
| BAVARIAN NORDIC A/S | Chief Executive Officer | 28.05.2014 |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Corporate Officer/Principal | 03.03.2011 |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | President | - |
Ausbildung von Paul Chaplin
| University of Bristol | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
